T J Postma

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20
    T J Postma
    Department of Neurology, VU University Medical Center, P O Box 7057, MB Amsterdam 1007, The Netherlands
    Eur J Cancer 41:1135-9. 2005
  2. ncbi request reprint Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer
    T J Postma
    Department of Neurology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    J Neurooncol 45:241-6. 1999
  3. ncbi request reprint A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma
    T J Postma
    Department of Neurology, University Hospital Vrije Universiteit Amsterdam, The Netherlands
    Ann Oncol 11:409-13. 2000
  4. pmc The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study
    I Bosma
    Department of Neurology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands
    J Neurooncol 88:77-85. 2008
  5. doi request reprint Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
    J Sigmond
    Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    Ann Oncol 20:182-7. 2009
  6. ncbi request reprint Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma
    T J Postma
    Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
    Neurology 59:121-3. 2002
  7. ncbi request reprint Interobserver variability in the radiological assessment of response to chemotherapy in glioma
    M J Vos
    Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
    Neurology 60:826-30. 2003
  8. ncbi request reprint [Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants]
    M Klein
    afd Medische Psychologie, Vrije Universiteit Medisch Centrum, Van der Boechorststraat 7, 1081 BT Amsterdam
    Ned Tijdschr Geneeskd 148:2175-80. 2004
  9. doi request reprint Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study
    F E Froklage
    Department of Neurology, SEIN Epilepsy Institute in the Netherlands Foundation, Achterweg 5, 2103 SW, Heemstede, The Netherlands
    J Neurooncol 116:387-94. 2014
  10. ncbi request reprint Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma
    M H J Swennen
    Department of Neurology, University Medical Centre Utrecht, The Netherlands
    J Neurooncol 66:333-9. 2004

Collaborators

Detail Information

Publications20

  1. ncbi request reprint The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20
    T J Postma
    Department of Neurology, VU University Medical Center, P O Box 7057, MB Amsterdam 1007, The Netherlands
    Eur J Cancer 41:1135-9. 2005
    ..The EORTC CIPN20 should provide valuable information on CIPN-related symptoms and functional limitations of patients exposed to potentially neurotoxic chemotherapeutic and/or neuroprotective agents...
  2. ncbi request reprint Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer
    T J Postma
    Department of Neurology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    J Neurooncol 45:241-6. 1999
    ..We conclude that peripheral neuropathy is dose-limiting in chemonaïve patients treated with biweekly TEC combination chemotherapy, at paclitaxel dose level 165 mg/m2 in a 3-h intravenous administration...
  3. ncbi request reprint A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma
    T J Postma
    Department of Neurology, University Hospital Vrije Universiteit Amsterdam, The Netherlands
    Ann Oncol 11:409-13. 2000
    ..The prognosis of malignant gliomas remains poor. In recurrent disease, chemotherapy can be considered...
  4. pmc The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study
    I Bosma
    Department of Neurology, VU University Medical Center, De Boelelaan 1117, Amsterdam, The Netherlands
    J Neurooncol 88:77-85. 2008
    ..We hypothesized that LGG patients show local as well as diffuse slowing of resting state brain activity compared to healthy controls and that particularly global slowing correlates with neurocognitive dysfunction...
  5. doi request reprint Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
    J Sigmond
    Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    Ann Oncol 20:182-7. 2009
    ..In tumor samples, both gemcitabine and dFdU concentrations are high enough to enable radiosensitization, which warrants clinical studies using gemcitabine in combination with radiation...
  6. ncbi request reprint Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma
    T J Postma
    Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
    Neurology 59:121-3. 2002
    ..White matter abnormalities were observed in six patients, all of whom were treated with prior radiotherapy. These radiologic cerebral abnormalities correlated with cognitive performance...
  7. ncbi request reprint Interobserver variability in the radiological assessment of response to chemotherapy in glioma
    M J Vos
    Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
    Neurology 60:826-30. 2003
    ..To assess the interobserver variability in the radiologic assessment of response to chemotherapy in patients with recurrent glioma...
  8. ncbi request reprint [Impaired cognitive functioning in low-grade glioma patients: relationship to tumor localisation, radiotherapy and the use of anticonvulsants]
    M Klein
    afd Medische Psychologie, Vrije Universiteit Medisch Centrum, Van der Boechorststraat 7, 1081 BT Amsterdam
    Ned Tijdschr Geneeskd 148:2175-80. 2004
    ..To determine the effects of radiotherapy and other medical interventions on cognitive functioning in patients with a low-grade glioma (LGG)...
  9. doi request reprint Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study
    F E Froklage
    Department of Neurology, SEIN Epilepsy Institute in the Netherlands Foundation, Achterweg 5, 2103 SW, Heemstede, The Netherlands
    J Neurooncol 116:387-94. 2014
    ..Furthermore, development or progression of pre-existing WMH and CA does not consistently result in functional impairment as measured by cognitive tests. ..
  10. ncbi request reprint Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma
    M H J Swennen
    Department of Neurology, University Medical Centre Utrecht, The Netherlands
    J Neurooncol 66:333-9. 2004
    ..In conclusion, both the incidence and the severity of abnormalities is greater in patients treated with WBRT and in older patients...
  11. ncbi request reprint Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening
    C C P Verstappen
    Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands
    Neurology 64:1076-7. 2005
    ..Furthermore, off-therapy worsening of symptoms (24%) and signs (30%) occurred unexpectedly...
  12. doi request reprint Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy
    Ellen S Mandl
    Department of Neurosurgery, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
    Surg Neurol 69:506-9; discussion 509. 2008
    ..The purpose of the study was to evaluate the effects, frequency, and complications of repeated surgical resection for GBM relapse...
  13. ncbi request reprint The prognostic value of cognitive functioning in the survival of patients with high-grade glioma
    M Klein
    Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands
    Neurology 61:1796-8. 2003
    ..Assessment of cognitive functioning in these patients may improve clinical decision making and thus quality of treatment...
  14. doi request reprint Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations
    P C Johannesma
    Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
    Clin Genet 80:243-55. 2011
    ..Identification of MMR protein defects can lead to early diagnosis of this condition. In addition, assays for these defects may help to classify brain tumours for research protocols aimed at targeted therapies...
  15. ncbi request reprint Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer
    C C P Verstappen
    Department of Neurology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands
    J Neurooncol 63:201-5. 2003
    ..To evaluate the peripheral neuropathic changes induced by combination chemotherapy including paclitaxel (taxol), gemcitabine and cisplatin (TGC regimen)...
  16. ncbi request reprint PCV chemotherapy for recurrent glioblastoma multiforme
    A C Kappelle
    Departments of Neurology and Medical Oncology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    Neurology 56:118-20. 2001
    ..Median TTP and survival were 13 and 33 weeks. Age < 40 years and Karnofsky Performance Status > or = 90 were associated with longer TTP and survival. PCV treatment was generally well tolerated...
  17. ncbi request reprint [Temozolomide in patients with a glioblastoma multiforme: new developments]
    J E C Bromberg
    Erasmus MC, locatie Daniel den Hoed Oncologisch Centrum, afd Neurooncologie, Postbus 5201, Rotterdam
    Ned Tijdschr Geneeskd 149:1376-8. 2005
    ..It is advisable to consider treating young patients with primary glioblastoma multiforme who are in good condition with concomitant and adjuvant temozolomide. Efficacy of temozolomide in recurrent glioblastoma multiforme is limited...
  18. ncbi request reprint Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study
    M Klein
    Department of Medical Psychology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands
    Lancet 360:1361-8. 2002
    ..We aimed to identify the specific effects of radiotherapy on objective and self-reported cognitive function, and on cognitive deterioration over time, in patients with low-grade gliomas treated with early radiotherapy...
  19. ncbi request reprint Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma
    S Koeppen
    Department of Neurology, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany
    J Cancer Res Clin Oncol 130:153-60. 2004
    ....
  20. ncbi request reprint The position of the neurologist in neuro-oncology
    W Grisold
    Ludwig Boltzmann Institute for Neurooncology, Vienna, Austria
    Eur J Neurol 9:201-5. 2002
    ....